UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 30.

Zimmermann, R; Fink, Daniel; Dedes, Konstantin J; Imesch, P; Ochsenbein-Kölble, Nicole. Wir möchten den Frauen Mut für eine normale Geburt machen. In: NZZ Sonderbeilage, 18 March 2016, p.5-8.

Imesch, P; Fink, D (2016). Neoplasien der weiblichen Geschlechtsorgane: Endometriumkarzinom. In: Kreuzer, K A; Beyer, J. Hämatologie und Onkologie. Fallorientierte Darstellung – rationale Diagnostik und Therapie. Stuttgart: Thieme, 390-394.

Imesch, P; Fink, D (2016). Neoplasien der weiblichen Geschlechtsorgane: Zervixkarzinom. In: Kreuzer, K A; Beyer, J. Hämatologie und Onkologie. Fallorientierte Darstellung – rationale Diagnostik und Therapie. Stuttgart: Thieme, 395-399.

Samartzis, E; Imesch, P; Twiehaus, A; Dubey, R K; Leeners, Brigitte (2016). The estrogen metabolites 2-methoxyestradiol and 2-hydroxyestradiol inhibit endometriotic cell proliferation in estrogen receptor independent manner. Gynecological Endocrinology, 32(7):529-533.

Ture, M; Barth, J; Angst, F; Aeschlimann, A; Schnyder, U; Zerkiebel, N; Perseus, J; Renner, C; Imesch, P; Fuchs, B; Huber, G F; Walt, H; Martin-Soelch, C; Jenewein, J (2015). Use of inpatient rehabilitation for cancer patients in Switzerland: Who undergoes cancer rehabilitation? Swiss Medical Weekly, 145:w14214.

Mueller, M; Eberhard, M; De Geyter, C; Häberlin, F; Hohl, M K; Imesch, P; Polli, C; Possover, M; Schiessl, K; Wenger, J M; Wunder, D (2012). Diagnostik und Therapie der Endometriose. Frauenheilkunde Aktuell, 21(2):28-34.

Imesch, P; Fink, D (2012). Fertilitätserhaltende Therapien bei Ovarial- und Borderline-Tumoren. Leading Opinions Hämatologie & Onkologie, (5):52-54.

Schmidt, A-M; Imesch, P; Fink, Daniel; Egger, H (2012). Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer. Gynecologic oncology, 125(3):604-609.

Leimbacher, B; Samartzis, N; Imesch, P; Dedes, K J; Fink, D; Canonica, C (2012). Inpatient and outpatient loop electrosurgery excision procedure for cervical intraepithelial neoplasia: a retrospective analysis. Archives of Gynecology and Obstetrics, 285(5):1441-1445.

Imesch, P; Samartzis, E P; Fink, D (2012). Medikamentöse Therapie der Endometriose. Ars Medici, (18):934-937.

Imesch, P; Samartzis, E P; Fink, D (2012). Medikamentöse Therapie der Endometriose. Gynäkologie, (3):17-21.

Imesch, P; Fink, D (2012). Nachsorge in de gynäkologischen Onkologie. Gynäkologie, (5):6-9.

Samartzis, E P; Imesch, P; Fink, D (2012). Pathogenese der Endometriose. Gynäkologie, (3):6-10.

Imesch, P; Samartzis, E P; Fink, D (2012). Prävalenz, Diagnostik und Therapie der Endometriose. info@gynäkologie, (3):19-21.

Imesch, P; Fink, D; Gabriel, N (2012). Was bringt ein Screening beim Ovarial- und Korpus-Ca? Leading Opinions Medizin für die Frau, (3):28-30.

Imesch, P; Hornung, R; Fink, D; Fedier, A (2011). Cordycepin (3'-Deoxyadenosine), an Inhibitor of mRNA Polyadenylation, Suppresses Proliferation and Activates Apoptosis in Human Epithelial Endometriotic Cells in vitro. Gynecologic and Obstetric Investigation, 72(1):43-49.

Imesch, P; Samartzis, E P; Fink, D (2011). Endometriose - eine epigenetische Erkrankung? Leading Opinions - Medizin für die Frau, 4(1):2-4.

Samartzis, N; Imesch, P; Dedes, K J; Samartzis, E P; Fedier, A; Fink, D; Caduff, R; Fehr, M K (2011). Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: A tissue microarray study. BMC Cancer, 11:463.

Imesch, P; Samartzis, E P; Schneider, M; Fink, D; Fedier, A (2011). Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin. Fertility and Sterility, 95(5):1579-1583.

Imesch, P; Goehrens, A; Fink, D; Fedier, A (2011). MLH1-deficient HCT116 colon tumor cells exhibit resistance to the cytostatic and cytotoxic effect of the poly(A) polymerase inhibitor cordycepin (3'-deoxyadenosine)in vitro. Oncology Letters, 3(2):441-444.

Schwager, K; Bootz, F; Imesch, P; Kaspar, M; Trachsel, E; Neri, D (2011). The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model. Human Reproduction, 26(9):2344-2352.

Imesch, P; Fink, D (2011). Zervixkarzinom. Therapeutische Umschau, 68(10):545-552.

Imesch, P; Samartzis, E P; Fink, D (2010). Endometriose – eine epigenetische Erkrankung? Endometriose Aktuell, (2):2-4.

Imesch, P; Fink, D (2010). Endometriose: Richtiges operatives Vorgehen bei unerfülltem Kinderwunsch. Leading Opinions. Medizin für die Frau, 3(3):10-12.

Imesch, P; Fink, D; Fedier, A (2010). Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells. Fertility and Sterility, 94(7):2838-2842.

Dedes, K J; Dedes, I; Imesch, P; von Bueren, A O; Fink, D; Fedier, A (2009). Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities. Anti-Cancer Drugs, 20(5):321-333.

Imesch, P; Dedes, K; Fink, D (2009). Laparoskopische Therapie des Korpuskarzinoms: Datenlage und Evidenz. Gynäkologisch-geburtshilfliche Rundschau, 49(3):111-116.

Imesch, P; Dedes, K J; Furlato, M; Fink, D; Fedier, A (2009). MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cells. International Journal of Oncology, 35(3):631-640.

Imesch, P; Fink, D (2008). Das Endometriumkarzinom: Epidemiologie, Präkanzerosen, Diagnostik, Therapie und Nachsorge. Schweizer Zeitschrift für Onkologie, (5):6-10.

Dedes, K J; Szucs, T D; Imesch, P; Fedier, A; Fehr, M K; Fink, D (2007). Cost-effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a model-based analysis of the HERA and FinHer trial. Annals of Oncology, 18(9):1493-1499.

This list was generated on Tue Jul 25 23:16:05 2017 CEST.